ESR1 and breast cancer: In contrast, TCGA breast cancers exhibit ESR1 truncations on DNA-level less than half as often (7 of 1080; 0.65%) as observed in endometrial cancer and had increased expression of exons 1–2, but not of the full DNA-binding domain (Appendix D).